RVPH Stock Summary and Trading Ideas (Reviva Pharmaceuticals Holdings | NASDAQ:RVPH)

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

What symbol and exchange does Reviva Pharmaceuticals Holdings shares trade?

Reviva Pharmaceuticals Holdings trades on the NASDAQ stock market under the symbol RVPH.

What is Reviva Pharmaceuticals Holdings stock price doing today?

As of March 9, 2026, RVPH stock price declined to $2.88 with 474,658 million shares trading.

What is Reviva Pharmaceuticals Holdings's Beta?

RVPH has a beta of 2.05, meaning it tends to be more sensitive to market movements. RVPH has a correlation of 0.05 to the broad based SPY ETF.

How much is Reviva Pharmaceuticals Holdings worth?

RVPH has a market cap of $336.53 million. This is considered a Small Cap stock.

What is the highest and lowest price Reviva Pharmaceuticals Holdings traded in the last 3 year period?

In the last 3 years, RVPH traded as high as $185.00 and as low as $2.86.

What are the top ETFs holding Reviva Pharmaceuticals Holdings?

The top ETF exchange traded funds that RVPH belongs to (by Net Assets): VTI, VXF.

Is Reviva Pharmaceuticals Holdings (RVPH) a good investment?

RVPH has underperformed the market in the last year with a price return of -87.5% while the SPY ETF gained +19.0%. RVPH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -79.2% and -40.0%, respectively, while the SPY returned -0.4% and -0.6%, respectively.

What are the support and resistance levels for Reviva Pharmaceuticals Holdings (RVPH)?

RVPH support price is $3.29 and resistance is $3.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVPH shares will trade within this expected range on the day.